1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Epiomic Epidemiology Series: Fabry Disease Forecast in 8 Major Markets 2015-2025

Epiomic Epidemiology Series: Fabry Disease Forecast in 8 Major Markets 2015-2025

  • October 2015
  • -
  • Black Swan Analysis Ltd
  • -
  • 42 pages

Summary

Table of Contents

Search Inside

Summary

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Fabry Disease in 8 Major Markets

Fabry disease is a lysosomal storage disorder, caused by a genetic defect in the alpha-galactosidase-A gene (?GLA-gene), localized on the long arm of the X-chromosome (Xq22). This gene is essential in the breakdown of fatty substances, otherwise substances like globotriaosylceramide, will accumulate in the arteries, narrowing them and reducing blood flow around the body. It is a multi-system disorder characterised by dermatologic angiokeratoma corporis diffusum and purpura haemorrhagica nodularis, but also affects ocular, auditory, cardiac, digestive and renal systems.

This report provides the current prevalent population for Fabry Disease across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Fabry disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Fabry disease include:

-Angiokeratoma
-Cornea verticillata (corneal whorling)
-Hearing loss
-Tinnitus
-Proteinurea
-Cardiac hypertrophy & arrhythmias
-Sweating dysfunction

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global Fabry disease’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the prevalence of the subdivided types of Fabry disease and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on Fabry disease’s prevalent population.
-Identify sub-populations within Fabry Disease which require treatment.
-Gain an understanding of the specific markets that have the largest number of Fabry disease patients.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Hearing Loss Forecast in 12 Major Markets 2017-2027

Epiomic Epidemiology Series: Hearing Loss Forecast in 12 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • February 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hearing Loss in 12 Major Markets Hearing loss results from pathologic conditions that affect the hearing pathway. These can be classed ...

Global Canal Hearing Aids Market 2017-2021

Global Canal Hearing Aids Market 2017-2021

  • $ 3500
  • Industry report
  • February 2017
  • by Infiniti Research Limited

About Canal Hearing Aids Canal hearing aids are the devices that are implanted in the ear canal for sound transmission to assist people with hearing loss. Technavio’s analysts forecast the global canal ...

Acute Sensorineural Hearing Loss Global Clinical Trials Review, H1, 2017

Acute Sensorineural Hearing Loss Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • February 2017
  • by GlobalData

Acute Sensorineural Hearing Loss Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Sensorineural Hearing Loss Global Clinical Trials Review, H1, 2017” provides ...


Download Unlimited Documents from Trusted Public Sources

Ear Disease Statistics in India

  • April 2017
    4 pages
  • Ear Disease  

    Ear, Nose, And ...  

  • India  

View report >

Global Nutrition Industry - Forecast

  • March 2017
    146 pages
  • Nutrition  

    Infectious Dise...  

  • World  

View report >

Asthma Statistics in Canada

  • March 2017
    16 pages
  • Respiratory Dis...  

    Asthma  

  • Canada  

View report >

Related Market Segments :

Ear Disease
Neurological Disorder

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.